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Abstract 
Congenital heart disease is the most common congenital birth defect, affecting 1.35 
million newborns every year. Though therapeutic techniques have been developed to assist 
those afflicted, new issues arise as those that have been treated may have a higher 
likelihood to pass on their cardiovascular defect to their children. Adhesion G protein-
coupled receptors are an increasingly studied member of the G protein-coupled receptor 
superfamily. aGPCRs have a wide array of molecular mechanisms that it affects; however, 
their role in the development of organ systems, specifically the cardiovascular system, is the 
focus of our research. When screening for aGPCRs within the cardiovascular system, the 
adgrl gene family was one family found to be expressed. Previous research has shown that 
various adgrl isoforms, such as adgrl2, play roles in cardiovascular development. 
Digoxigenin-UTP RNA probes developed through TA-vector cloning and transformation 
into E. coli were used to reveal mRNA expression in in-situ hybridization (ISH). ISH 
reveals that the adgrl isoforms 1 and 3 are expressed in the cardiovascular system, similar 
to adgrl2. Using CRISPR/Cas9 technology, adgrl1 and adgrl3 mutant lines were generated 
and, once stable, will be screened and assessed for deviant phenotypes to elucidate their 
role in the cardiovascular system. Additional efforts have demonstrated another gene 
family, bai, is expressed in dorsal forerunner cells, which influence the flow of fluid within 
Kupffer’s Vesicle, establishing asymmetry within the brain, gut, and heart. Mutant bai2-/- 
and bai2l-/- zebrafish initially demonstrated similar deviations in left-right asymmetry 
randomization but were eventually lost in successive generations. When stable homozygous 
mutants for both mutations were developed, no deviant phenotypes were observed, 
potentially due to their redundant roles. To assess this possibility, bai2-/- and bai2l-/- mutants 
were crossed and double homozygous mutants’ phenotypes will be assessed when mature.  
 
Introduction 
Congenital heart disease is the most common congenital defect, affecting 1-2% of 
newborns, often leading to infant mortality (Fahed, Gelb, Seidman, & Seidman, 2013). 
Congenital heart disease accounts for more than a third of all congenital birth defects with 1.35 
million children a year being born with a congenital heart defect (Fahed et al., 2013). Modern 
medical interventions have been able to treat newborns with congenital heart disease; however, 
they often encounter further cardiovascular maladies later in life, such as cardiac arrhythmias 
(Ransom & Srivastava, 2007). Furthermore, there is also concern that those affected with 
congenital heart defects have a higher likelihood to pass the defect onto their children, thus 
replicating the deadly cycle (Ransom & Srivastava, 2007). Congenital heart disease arises within 
early heart development as the result of both environmental factors such as teratogens as well as 
genetic abnormalities (Fahed et al., 2013). 
Previous studies have implicated that adhesion G protein-coupled receptors (aGPCRs) 
play a key role in heart development (Doyle et al., 2006). Consisting of 33 family members in 
humans, aGPCRs are characterized by autocatalytic processing at a GPS Autoproteolysis 
INducing (GAIN) domain, multiple domains in long N termini, and strong evolutionary 
conservation (Hamann et al., 2015). aGPCRs have a wide array of roles within the organism, 
including but not limited to establishing cell polarity, cell adhesion and migration, cell size, 
tumorigenesis, and development of organ systems (Hamann et al., 2015). Indeed, previous 
efforts have demonstrated that knocking out certain aGPCRs leads to serious and sometimes fatal 
complications within specific organ systems (Hamann et al., 2015). For example, one aGPCR, 
adgrg6, leads to highly lethal mutations such as myocardial wall thinning and mitochondrial 
dysfunction in embryos when it is knocked out. (Patra et al., 2013). Since aGPCRs are tightly 
linked to the proper development of the cardiovascular system, it is critical to elucidate their 
function in order to develop therapeutic techniques to provide more competent, individualized 
care for those with congenital maladies.  
aGPCRs were screened for in cardiac cells, and it was found that two gene families have 
high expression levels: adgrl and brain-specific angiogenesis inhibitor (bai). Both families have 
multiple isoforms that contribute to different aspects to cardiovascular morphology (Hamann et 
al., 2015). The adgrl gene family is characterized by long N termini containing a rhamnose-
binding lectin (RBL) domain, hormone receptor motif (HRM), an olfactomedin domain, seven 
putative transmembrane domains, and a GAIN domain. In addition, they contain the latrophilin 
receptor, a unique characteristic to the family (Hamann et al., 2015). The adgrl gene family has 
been shown to be expressed in the nervous system and cardiovascular system (Hamann et al., 
2015). Presently, the roles of only a few members of adgrl have been established in the 
cardiovascular system. For example, a study demonstrated that knocking out adgrl2 leads to 
lethal mutations that inhibit atrioventricular cushion EMT through diminishment of 
mesenchymal cells in mice (Doyle et al., 2006). The atrioventricular canal endothelial cells form 
heart valves after an epithelial-mesenchymal transition (EMT) and, when adgrl2 is knocked out, 
leads to a reduction in migration ability in endothelial cells (Doyle et al., 2006). Another 
isoform, adgrl4, is expressed in endothelial cells and regulate angiogenesis in Zebrafish 
(Hamann et al., 2015). In the nervous system, the roles of adgrl1 and adgrl3 have already been 
established. Adgrl1 and adgrl3 deletions are risk factors for nervous system ailments such as 
mental retardation and hyperactivity; however, their function in the cardiovascular system is still 
unknown (Bonaglia et al., 2010).  
 The bai gene family is characterized by leucine-rich repeat N termini, an HRM, seven 
transmembrane domains, and long C termini (Hamann et al., 2015). Original research illustrates 
that the bai gene family is predominant in the neurons of the nervous system; however, novel 
data demonstrate that the deletion of bai isoforms also results in cardiovascular defects (Duman 
et al., 2013). Bai2 is an isoform found to be expressed in dorsal forerunner cells (DFCs), cells 
that form Kupffer’s Vesicle (Bakkers, Verhoeven, & Abdelilah-Seyfried, 2009). Kupffer’s 
vesicle is a ciliated organ that acts as the primary left-right organizer for the brain, gut, and heart 
by influencing the direction of the flow of fluid within the organ. (J. J. Essner, J. D. Amack, M. 
K. Nyholm, E. B. Harris, & H. J. Yost, 2005). The directionality of fluid-flow within Kupffer’s 
Vesicle induces the expression of nodal-related genes that are responsible for the development of 
asymmetrical organs, a requirement for proper organism development (Jeffrey J. Essner, Jeffrey 
D. Amack, Molly K. Nyholm, Erin B. Harris, & H. Joseph Yost, 2005). Asymmetrical formation 
of organs during embryogenesis is a highly conserved process throughout evolution and, when 
disrupted, can lead to birth defects (Blum, Feistel, Thumberger, & Schweickert, 2014). Two 
mutant lines were generated by a postdoctoral fellow: bai2-/-, a 16 base pair insertion causing a 
frameshift at the GPS domain, and bai2l-/-, a four base pair insertion located at the N terminus 
that causes a frame-shift and subsequent truncated protein. After injection, F0 mutants were 
crossed to generate mutant lines. Initially, both mutations demonstrated similar defects in left-
right asymmetry; however, the defect is gradually lost in later progenies. Both mutations have 
been reinjected into embryos and were allowed to grow to maturity and examined for phenotypic 
variations. 
 My research goal is to elucidate the roles of adgrl and bai gene families in heart 
development and LR asymmetry. Specifically, I will assess the expression patterns of isoforms 
adgrl1 and adgrl3 and their role in heart development through mutant generation via 
CRISPR/Cas9 technology. I expect adgrl1 and adgrl3 are also present in the heart and have a 
key function in heart development, when deleted, caused lethal mutations similar to results seen 
for adgrl2 in mice. Moreover, I postulate that bai2 mutants will exhibit left-right asymmetry 
defects when bai2, as well as purported compensatory genes, are knocked out. Once stable 
mutant lines are generated and maintained, I expect to see variations in heart formation and LR 
asymmetry when comparing mutants and wild type phenotypes. Finally, once bai2 and other 
compensatory genes are reinserted into the mutant line, I propose that LR asymmetry will 
dissipate in most offspring, confirming the role of bai2 in cardiac laterality.  
 
Materials and Methods 
 
Zebrafish Strains and Maintenance 
 AB*/Tuebingen, transgenic Tg myl7:EGFP) (Huang, Tu, Hsiao, Hsieh, & Tsai, 2003), 
and Tg(sox17:EGFP) (Mizoguchi, Verkade, Heath, Kuroiwa, & Kikuchi, 2008) zebrafish strains 
were maintained as described (Xu, Echemendia, Chen, & Lin, 2011). Embryos utilized for 
experimental purposes were obtained from NIH Zebrafish strains. All embryos were obtained 
through mating and were grown at 28.5ºC or 32ºC and were staged according to morphology and 
hours post fertilization. 
 
Database Research 
Potential zebrafish homologs of adgrl were identified using the following databases: 
NCBI, Ensembl, and The Zebrafish Model Organism Database. To determine homology between 
the human and zebrafish adgrl transcripts, Clustal Omega online software aligned available 
database amino acid information and quantified the percent similarity of each species. 
 
 
 
 
Cloning Zebrafish Partial adgrl Genes for in-situ hybridization  
To examine the expression of the adgrl isoforms, cloned partial genes were used to 
generate antisense RNA probes for in-situ hybridization. Primers were designed to span ~1 kb of 
Human Genetics (table 1).  
 
 Table 1: Forward and reverse primers for adgrl1 and adgrl3. 
 
Amplification of the target region was completed through polymerase chain reaction of 
cDNA obtained from wild-type 30 hour and 5 day zebrafish RNA using RT-PCR. A 20 µL 
reaction containing 1 µL cDNA and 0.5 µL of forward and reverse primer (10mM), 1.6 µL 
dNTP (2.5mM), 1 unit of taq polymerase, and 1 unit of taq buffer was placed in a thermocycler 
and utilized the appropriate annealing temperatures. The PCR product was fractioned by a 1% 
agarose gel electrophoresis to assess for the correct size. Finally, the PCR product was purified 
using an IBI Scientific PCR Clean-up and Gel Extract Kit. 
 
TA Vector Insertion 
 The purified PCR product was ligated into a pGEM-T Easy Vector. A 5 µL reaction was 
created with 0.5 µL T4 DNA ligase (3 Weiss units/ µL), 2.5 µL 2x Rapid Ligation Buffer, 1 µL 
PCR product, 1 µL pGEM-T Easy Vector (50ng), and 0.5 µL homemade ddH2O. DH5 
competent cells stored at -80ºC were thawed on ice. 50 µL of competent cells were added to the 
ligation reaction and placed on back on ice for 20 minutes. The cells were then heat shocked for 
45-50 seconds and immediately put back on ice for 2 minutes. Cells were plated onto lysogeny 
broth (LB) plates containing the appropriate antibiotic and incubated over night at 37ºC 
overnight. Cells showing proper insertion of the PCR product appeared white on the plate. White 
colonies were collected and grown in a 15 mL tube with a 1:1 ratio of appropriate antibiotic and 
LB medium at 37ºC overnight. 
 
 
 
 Forward Reverse 
Adgrl1 5’-CACTGCTGACACAGGTC-3’ 5’-TTAGTGATCTCACCTTCTGGG-3’ 
Adgrl3 5’-GCTCGGGATACAAGTGCC-3’ 5’-GCCAGCCGAAAGCTCATC-3’ 
Restriction Enzyme Digestion 
 To test if plasmid contains the correct plasmid and to determine the direction of the 
sequence, the plasmid was digested. 2 µL of restriction enzyme (sp6 or T7 depending on the 
directionality of the sequence) as well as 10 µL of the appropriate buffer were added to 10000ng 
of the plasmid. Then, ddH2O was added to create a 100 µL reaction and was placed in a 37ºC 
water bath for 2 hours. Finally, the plasmid ran on a 1% agarose gel for confirmation. Linearized 
plasmids were sequenced to determine the directionality of the insert. 
 
RNA Probe Synthesis, Purification, and Verification 
 Digoxigenin-UTP-labeled RNA probes were synthesized according to Roche DIG RNA 
Labeling Kit and protocol. Briefly, 1 µg of linearized DNA (quantified by UV light absorption), 
1 µL transcription buffer, 2 µL NTP-DIG-RNA, 1 µL RNAse inhibitor, 2 µL enzyme mix, and 
nuclease-free water to 20 µL were added to a 1.5 mL microcentrifuge tube and mixed by 
pipetting. The mixture incubated at 37ºC for two hours. After two hours, 1 µL TURBO DNase 
was added to the sample and incubated for 15 minutes at 37ºC to remove extraneous template 
DNA. To purify the RNA, 2 µL 0.2 M EDTA, 2.5 µL 4M LiCl, and 75 µL cold 100% ethanol 
were added to the reaction and spun down at 12,000 rpm for 30 minutes at 4ºC. The supernatant 
was extracted and the RNA pellet was re-suspended and washed with 70% ethanol and spun 
down again for 3 minutes to pellet the RNA. Finally, the sample was eluted with 50 µL 
diethylpyrocarbonate (DEPC) water at pH 8 instead of elution buffer or ddH2O
4. DEPC water is 
used as an eluent due to its RNase-free property and reduces the risk of RNA being degraded by 
RNases. RNA concentrations were determined by UV light absorption and were confirmed by 
fractioning on a 1% agarose gel. 
 
Whole Mount In-situ Hybridization 
 To determine the amount and location of gene location, in-situ hybridization was 
performed on different developmental stages, including but not limited to eight-cell, 16-cell, 32-
cell, shield, 22-somite, 1-day post-fertilization, 2-days post-fertilization, and 3-days post-
fertilization. Sense and antisense RNA probes for adgrl1A and adgrl3 were synthesized 
according to protocol. In-situ hybridization was performed as described (Lin et al., 2005). 
 
Cloning-Free gRNA Synthesis 
 Cloning-free gRNA synthesis was used to generate gRNA for CRISPR/Cas9 targeting. 
Using previous genomic information obtained from database mining, gRNA sequences were 
chosen based on the probability of off-site targeting. Potential off-site targets were detected using 
ZiFiT targeting software and the gRNA with the lowest probability of off-site targeting was 
chosen. A clamp, T7 promotor sequence, NGG sequence, guide sequence, and overlap sequence 
were assembled into a specific oligonucleotide and was annealed to a generic oligonucleotide 
with a complementary overlap sequence (table 2). A 20 µL annealing reaction consisted of 1 µL 
20x taq buffer, 0.8 µL 2.5 mM dNTPs, 2 µL 10 µM specific oligonucleotide, 2 µL 10 µM 
generic oligonucleotide, 0.3 µL 100% DMSO, 1 µL homemade taq polymerase, and 2.9 µL H2O. 
The mixture was denatured at 95ºC for 2 minutes, annealed at 50ºC for 10 minutes, extended at 
70ºC for 10 minutes, denatured again at 95ºC for 5 minutes, and was removed to room 
temperature and allowed to cool. Confirmation of proper annealing was obtained on a 3.5% 
agarose gel.  
 
 Oligonucleotide A 
Adgrl1 5’-GCGTAATACGACTCACTATAGGCAGCAAGTTTGCTGCAGGGTTTTAGAGCTAGAAATAGC-3’ 
Adgrl3 5’-GCGTAATACGACTCACTATAGGTGGACGAAAACGGCCTCTGTTTTAGAGCTAGAAATAGC-3’ 
 
Table 2: Specific oligonucleotide ordered for both adgrl1 and adgrl3. Each oligonucleotide contains a clamp, 
T7 promotor sequence, PAM site (NGG sequence), guide sequence, and overlap sequence.  
 
gRNA Injection and Mutation Analysis  
 1nL of a mixture containing 80ng/ µL of nls-zCas9-nls mRNA and 40 ng/µL gRNA 
created in the aforementioned protocol was injected into the blastomere of the wild-type embryos 
at 1-cell stage. To determine if gRNAs created mutations, genomic DNAs from pools of 5 
injected embryos were isolated and amplified using primers flanking the region where the 
potential mutations could occur (table 3). Potential mutations were analyzed by polyacrylamide 
gel electrophoresis (PAGE) as polymorphisms run at different rates. (table 3).  
 
 
 Genotyping 
Groups of embryos or tails of adult fish were used to isolate genomic DNAs. The 
embryos were combined into groups of five and lysed in 0.5 µL proteinase K with 10 µL of lysis 
buffer and were incubated for eight hours at 55ºC and thirty minutes at 98ºC to denature the 
proteinase K. Samples underwent similar PCR conditions as before and were analyzed via PAGE 
gel. Samples were electrophoresed 2% agarose gel, cleaned using an IBI Scientific PCR Clean-
up and Gel Extract Kit4, and were sent for sanger sequencing at the Iowa Institute of Human 
Genomics if they demonstrated a novel mutation. 
 
RNA Isolation and RT-PCR Gene Expression Analysis 
 To determine the relative expression of the adgrl gene family across model organisms, 
adult mouse heart sample was reverse transcribed to generate cDNA. Using 1 mL Ambion 
TRIzol Reagent, a solution highly effective in RNase activity inhibition and dissolving cell 
components, the sample was homogenized (Ambion). To separate aqueous and organic phases, 
0.2 mL chloroform per 1 mL TRIzol Reagent was added, shaken vigorously, and allowed to 
incubate at room temperature for 3 minutes. The sample was centrifuged at 12,000 x g for 15 
minutes at 4ºC, permitting the solution to separate into a lower organic phase, interphase, and an 
upper aqueous phase, where the RNA was located. The aqueous phase was removed and 
transferred into a new tube. The RNA was isolated from the aqueous phase using 0.5 mL 100% 
isopropanol per 1 mL TRIzol Reagent and incubated at room temperature for 10 minutes. It was 
centrifuged for 10 minutes at 12,000 x g at 4ºC. Once an RNA pellet formed, the pellet was 
washed with 1 mL 75% ethanol per 1 mL TRIzol Reagent, briefly vortexed to re-suspend the 
pellet, and centrifuged at 7,500 x g for 5 minutes at 4ºC. the wash was discarded, and 30 µL of 
RNase-free water was added to re-suspend the RNA pellet. The sample was incubated in a 55ºC 
water bath for 15 minutes and stored at -80ºC. (). To synthesize cDNA from the isolated RNA, 
 Forward Reverse 
Adgrl1 gRNA  5’-CCGTCCTTCTATGCGTT-3’ 5’-GTCTTCCCATGAAGCATACTC-3’ 
Adgrl3 gRNA  5’-AAACTCCCGCACCGAGTG-3’ 5’-GTCCCACGTTCCCTCGAC-3’ 
Table 3: Flanking primers for the gRNA site within the genomic DNA. Flanking primers are used to verify the 
efficacy of CRISPR/Cas9 technology and amplify the target region for mutation analysis. 
 
an Invitrogen Cloned AMV First-Strand cDNA Synthesis Kit was used. A mixture of 1 µL 
random hexamer, 2 µL 10mM dNTP, and 9 µL RNA were added to a 0.5 mL tube. The mixture 
was placed in a 65ºC water bath for 5 minutes to denature the RNA and was immediately placed 
on ice. 4 µL 5cDNA buffer, 1 µL .1M DTT, 1 µL RNase Out, 1 µL DEPC-treated water, and 1 
µL AMV were added to the previous mixture and placed in a thermocycler at 25ºC for 10 
minutes, 55ºC for 60 minutes, and 85ºC for 5 minutes. The newly prepared cDNA was stored in -
20ºC. 
 
Results 
 
Identification of Genes  
Database research confirmed the existence of four isoforms of adgrl within the human 
genome. It was found that zebrafish contain homologs to the human and mouse adgrl gene 
sequences, adgrl1, adgrl2a, adgrl2b, adgrl3, and adgrl4. 
Located on chromosome 3 in zebrafish and 
chromosome 19 in humans, adgrl1 (Ensembl ID 
ENSDART00000124480.2) contains 1522 amino acids with 
an open reading frame (ORF) and is 71% and 85% similar 
to the human and mouse homolog, respectively (Fig. 2A). 
In addition, adgrl3 is located on chromosome 7 in zebrafish 
and chromosome 4 in humans. It also contains an ORF 
encoding 1347 amino acids and shares 69% and 70% 
similarity with the human and mouse homolog, respectively 
(Ensembl ID ENSDART00000171848.1) (Fig. 2B). 
 Utilizing the available database sequences, primers were developed and used to amplify 
previously generated cDNA from 30-hour post-fertilization and 5-day wildtype zebrafish, our 
results showed bands at the expected size, indicating that adgrl3 is expressed in the zebrafish 
genome at these stages (Fig. 1). Amplicon size for adgrl1 is 945 base pairs while adgrl3 is 771 
base pairs. 
 
 
 
Fig. 1. 1% Agarose gel confirming the presence of 
adgrl3 in zebrafish at 30 hpf and 5 dpf. Amplicon 
size is ~771 base pairs.  
Linearized Plasmid Confirmation 
 Purified PCR product was transformed into 
DH5 competent cells and were purified successfully. 
Confirmation by agarose gel electrophoresis (Fig. 3) 
shows that the plasmid was approximately 3,000 base 
pairs. Sequencing of adgrl1a showed the insert had 
antisense directionality and was linearized with SalI 
with T7 transcription buffer. Conversely, adgrl3 
sequencing showed in-sense directionality and was cut 
using ApaI with SP6 transcription buffer. 
 
 
RNA Probe Verification  
 RNA was successfully synthesized and 
purified using the methods mentioned above. 
Adgrl1 shows successful RNA probe creation; 
however, adgrl3 shows the presence of multiple 
bands when fractioned by a 0.8% agarose gel. 
Adgrl3 was remade with new reagents to ensure 
proper techniques and protocols were followed, 
but agarose gel fractioning showed the same 
results. Overall, both adgrl1 and adgrl3 had the 
proper RNA probe size (~300bp) (Fig. 4). 
 
 
 
 
 
Fig. 3. 1% Agarose gel confirming the proper 
linearization of adgrl1 into the vector. Product 
size shown ~3000 base pairs.  
 
 
Fig. 4. 0.8% Agarose gel containing (from left to right): 
an RNA ladder, a positive control, adgrl1, and adgrl3. 
RNA probe size ~300bp for both isoforms.  
 A 
 
B 
 
 
Fig. 2A,2B. Comparison of zebrafish (Danio rerio), human (Homo sapiens), and mouse (Mus 
musculus). A, B: Amino acid sequence alignment adgrl1 (A) and adgrl3 (B) created using Clustal 
Omega program (http://www.ebi.ac.uk/Tools/msa/clustalo/). Amino acids are numbered on the 
right of each figure. Asterisks indicate identical matches, periods and colons indicate a match 
between two of the sequences. 
Expression of adgrl1 and adgrl3 
 Whole-Mount in-situ hybridization revealed information about the expression location 
and timing of adgrl1 and adgrl3. Adgrl1 showed expression levels within the eight-cell and 16-
cell stages, demonstrating a maternal deposition of the gene (Fig. 5A,5B). As the embryo 
undergoes gastrulation, adgrl1 is found to be expressed throughout the entirety of the animal 
pole, hinting at a possible role in early development (Fig. 5C). As gastrulation and somitogenesis 
occurs, adgrl1 localizes to the hindbrain, midbrain, and forebrain, as seen in Fig. 5D. as well as 
near the location of the heart. Strikingly, adgrl1 also hybridized in the location of the heart cone, 
a primitive stage of the heart (Fig. 5E). One can clearly see the expression levels within the 
brain, heart, and blood vessels at 26-hours post fertilization (Fig. 5F), as illustrated by the dark 
staining around the head and throughout the vasculature on the back. At day 2, staining is 
confined to the brain and heart and slight staining in the vessels (Fig. 5G,5H). Finally, at day 3, 
staining seems to be isolated in the heart, midbrain, and hindbrain (Fig. 5I).  
 Similar to adgrl1, adgrl3 was found to be expressed in early blastula, eight-cell and 16-
cell stages, once again implying maternal contribution (Fig. 6A,6B). It is expressed throughout 
during gastrula (Fig. 6C) and localizes in the heart and brain throughout somitogenesis. 
Specifically, adgrl3 is highly expressed within the heart cone and brain at 22-somite, as seen in 
the dorsal view (Fig. 6D,6E). As the embryo matures, adgrl3 becomes more confined to the 
brain and cardiovascular system, as seen in Fig. 6F-6H, 6J-6K, until its high expression is clearly 
visible at day 3 (Fig. 6I).  
 
Adgrl Expression in Mouse Heart 
 As previously mentioned, adgrl2 (latrophilin-2) was found to be expressed within mouse 
endothelial cells in the atrioventricular canal. To determine whether other adgrl isoforms are 
present in the mouse heart, primers were developed for adgrl1, adgrl2, adgrl3, and adgrl4. It 
was shown that adgrl2 and adgrl4 were highly expressed in mouse cardiac tissue when 
compared to a housekeeping gene, glyceraldeyde-3-phosphate dehydrogenase (GAPDH).  
 
Bai2 Phenotype Expression 
 Previously injected bai2 mutants from post-doctoral candidates have generated F1 
mutants that have been assessed for a deviant phenotype. The F1 generation were maintained and 
generated for the two mutations, and bai2-/- and bai2l-/-. Bai2l-/- F1 mutants were crossed and 24 
embryos were collected. The embryos were assessed for the mutant phenotype at 22-somite. No 
mutants exhibited heart laterality defects. When bai2-/- homozygous mutants were crossed, all 83 
embryos demonstrated normal left-side cardiac laterality. 
 
Adgrl Mutation Analysis 
 F0 injected mutants were screened 
to determine the efficacy of the injection 
procedure. Fig. 7 shows the F0 injection 
results of adgrl1 and adgrl3 when 
compared to controls. Mutant 
polymorphism bands can be clearly seen in 
all four samples in adgrl1, illustrating a 
high efficacy rate. Conversely, adgrl3 
injected mutants demonstrated a low 
efficacy as only one of the four samples demonstrated mutations. However, the all injected F0 
progeny was allowed to continue to 
grow to see if there would be any 
mutations shown in F1 progeny. 
Currently, adgrl injected 
Zebrafish have demonstrated 
transmissible mutations as seen in their 
a F1 progeny when crossed with the 
wildtype genotype. Fig. 8 illustrates 
one type of mutation that from adgrl3 
F1 progeny on a 10% PAGE gel that 
was been submitted for sanger 
sequencing. Sequencing results 
determined that the mutation in Fig. 8 
was a frame-shift that was observed on 
 
 
 
 
Fig. 8. Mutation analysis of F1 adgrl3 mutants via 10% PAGE gel. Three 
extra bands appear in samples 1,2, and 3 when compared to controls. Below, 
sequencing results demonstrated a 5 base pair insertion in the mutant had 
occurred, causing a frame-shift mutation as denoted in red.  
 
    
 
Fig. 7. F0 mutant injection confirmation of adgrl1 and adgrl3. Efficacy of 
injection can be seen when compared to control samples. Adgrl1 
demonstrates multiple polymorphisms as visualized by the 
extemporaneous bands above the control DNA in all samples. 
Conversely, adgrl3 shows only one extemporaneous band above the 
control DNA, illustrating a low efficacy.  
the PAGE gel. The frame-shift was a 5 base pair insertion, creating new serine and valine amino 
acids (Fig. 8).  
 
Discussion 
 
Adgrl Gene Family 
As previously discussed, it has been demonstrated that all three isoforms, adgrl1, adgrl2, 
and adgrl3 exist within the Zebrafish genome and have been successfully amplified, targeted, 
and located within the organism. Using whole mount in-situ hybridization, I confirmed the 
presence of adgrl1 and adgrl3 genes in the cardiovascular system. It appears that adgrl1 is 
expressed ubiquitously throughout the embryo in blastula and gastrula stages, then is confined to 
the nervous and cardiovascular system. I have injected wildtype embryos with gRNA to create 
mutations in adgrl1. When the F0 line grows to maturity, they will be screened to assess the type 
of mutation that occurred. The F0 generation will then be in-crossed to generate F1 mutant 
progeny that will be assessed for phenotypic variations.  
  Adgrl3 expression appears to be similar to that of adgrl1 in many aspects including 
temporal and spatial characteristics; however, it appears that adgrl3 is more strongly expressed 
in the cardiovascular system than in the nervous system. In contrast to adgrl1, adgrl3 exhibits 
higher expression levels in the cardiovascular system, illustrated by the darker staining seen in 
ISH. This is clearly evident when one compares the anterior images of the day 2 embryos, Fig. 
5G and Fig. 6K, for adgrl1 and adgrl3, respectively. It is clear that, though there is expression of 
adgrl1 in the heart, the level of expression differs vastly between the two isoforms. The level of 
expression within the heart for adgrl3 is strong enough that it is possible to clearly see the atria 
and ventricle; leading to the belief that there is a substantially higher level of expression of 
adgrl3 than adgrl1 in the heart and implying that adgrl3 may play a more dominant role in heart 
development than adgrl1. Like adgr1l, a mutant generation of zebrafish are being screened for 
sequence mutations and will be used to establish a stable line of mutants for phenotypic 
observation. One adgrl3 mutation has already been observed in the F0 injected mutants. Five 
base pairs have been inserted into this sample and may generate a stop codon; however, since the 
entirety of the genomic sequence is not known, it may be difficult to determine whether a 
premature stop codon has been generated. As such, this mutant will be used to grow F1 progeny, 
generate stable mutant lines, and monitored for any mutant phenotypes. 
 
Bai Gene Family  
 As aforementioned, all F1 bai2 mutant embryos did not show any deviation in the 
phenotype, suggesting that either the mutation did not result in a frame-shift mutation and 
subsequent truncated protein, allowing the protein to continue functioning normally or other 
genes from the bai gene family were compensating for the loss of function from the mutation. To 
ensure there was a frame-shift mutation, the mutant DNA was sequenced. The sequence 
demonstrated that the mutation had worked as intended, thus leading to another explanation: the 
two mutations, since they display similar phenotypic defects in embryos, may be playing 
redundant roles and, when one site is mutated, the other allows the organism to grow normally. 
To determine whether they are redundant, bai2-/- and bai2l-/- mutants were crossed with each 
other. Double homozygote mutants will, when mature, be genotyped, sequenced, and observed 
for any possible phenotypic variation.  
The goals of this research project are as follows: assessing the expression patterns and 
locations of adgrl1, adgrl3, and bai2 isoforms and generating mutant lines to determine their 
respective roles in heart development. The results have demonstrated that adgrl1 and adgrl3 
isoforms are present within the cardiovascular system and support the decision to generate 
mutant lines for further study. Moreover, they have demonstrated a lack of phenotype in bai2-/- 
and bai2l-/- mutants, possibly due to the two genes playing redundant roles. I will be continuing 
to develop double homozygous mutants to rule out the possibility of redundancy. As the project 
develops, I expect to have stable adgrl1, adgrl3, and bai2-/-/bai2l-/- mutant lines from which to 
assess their functions in cardiovascular development. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. expression of adgrl1 during zebrafish embryogenesis. A-I: Whole mount in-situ hybridization revealed 
expression patterns at various stages: eight-cell (A), 16-cell (B), shield (C), 22-somite (D-E)), 26-hour post-
fertilization (F), day 2, and day 3 (I).  
 
 
Fig. 6 expression of adgrl3 during zebrafish embryogenesis. A-K: Whole mount in-situ hybridization revealed 
expression patterns at various stages: eight-cell (A), 16-cell (B), shield (C), 22-somite (D-E), day 1 (F), 26-hour post-
fertilization (G), day 2 (H), day 3 (I), 48-hour post-fertilization (J-K). 
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